70 related articles for article (PubMed ID: 7587951)
21. Structure-function of cytochromes P450 and flavin-containing monooxygenases: implications for drug metabolism.
Halpert JR; Domanski TL; Adali O; Biagini CP; Cosme J; Dierks EA; Johnson EF; Jones JP; Ortiz de Montellano P; Philpot RM; Sibbesen O; Wyatt WK; Zheng Z
Drug Metab Dispos; 1998 Dec; 26(12):1223-31. PubMed ID: 9860932
[TBL] [Abstract][Full Text] [Related]
22. Reconstitution premixes for assays using purified recombinant human cytochrome P450, NADPH-cytochrome P450 reductase, and cytochrome b5.
Shaw PM; Hosea NA; Thompson DV; Lenius JM; Guengerich FP
Arch Biochem Biophys; 1997 Dec; 348(1):107-15. PubMed ID: 9390180
[TBL] [Abstract][Full Text] [Related]
23. Functional interactions in cytochrome P450BM3. Fatty acid substrate binding alters electron-transfer properties of the flavoprotein domain.
Murataliev MB; Feyereisen R
Biochemistry; 1996 Nov; 35(47):15029-37. PubMed ID: 8942669
[TBL] [Abstract][Full Text] [Related]
24. Oxidation of the antihistaminic drug terfenadine in human liver microsomes. Role of cytochrome P-450 3A(4) in N-dealkylation and C-hydroxylation.
Yun CH; Okerholm RA; Guengerich FP
Drug Metab Dispos; 1993; 21(3):403-9. PubMed ID: 8100494
[TBL] [Abstract][Full Text] [Related]
25. Cytochrome P-450 dependent biotransformation: some recent developments. Introductory remarks: cytochromne P-450 mixed function oxygenases.
Finlayson MJ; Bellward GD
Proc West Pharmacol Soc; 1980; 23():1-2. PubMed ID: 7403109
[No Abstract] [Full Text] [Related]
26. Chemical mechanisms of halocarbon metabolism.
Macdonald TL
Crit Rev Toxicol; 1983; 11(2):85-120. PubMed ID: 6340969
[No Abstract] [Full Text] [Related]
27. Inhibition of trazodone metabolism by thioridazine in humans.
Yasui N; Otani K; Kaneko S; Ohkubo T; Osanai T; Ishida M; Mihara K; Kondo T; Sugawara K; Fukushima Y
Ther Drug Monit; 1995 Aug; 17(4):333-5. PubMed ID: 7482685
[TBL] [Abstract][Full Text] [Related]
28. QSAR of P450 oxidation: on the value of comparing kcat and km with kcat/km.
Gao H; Hansch C
Drug Metab Rev; 1996 Nov; 28(4):513-26. PubMed ID: 8959390
[No Abstract] [Full Text] [Related]
29. Quantitative structure-activity relationships of cytochrome P-450.
Hansch C; Zhang L
Drug Metab Rev; 1993; 25(1-2):1-48. PubMed ID: 8449144
[No Abstract] [Full Text] [Related]
30. Cytochrome P-450 and oxidative metabolism in invertebrates.
Livingstone DR
Biochem Soc Trans; 1990 Feb; 18(1):15-9. PubMed ID: 2185077
[No Abstract] [Full Text] [Related]
31. [Cytochrome P-450 enzymes].
Pelkonen O; Lang M; Sotaniemi E
Duodecim; 1990; 106(7):555-62. PubMed ID: 1670212
[No Abstract] [Full Text] [Related]
32. Mixed-function oxidation of histidine residues.
Levine RL
Methods Enzymol; 1984; 107():370-6. PubMed ID: 6503718
[No Abstract] [Full Text] [Related]
33. An improved and updated version of the compact procedure for the evaluation of P450-mediated chemical activation.
Lewis DF; Ioannides C; Parke DV
Drug Metab Rev; 1998 Nov; 30(4):709-37. PubMed ID: 9844807
[No Abstract] [Full Text] [Related]
34. Anandamide hydrolase: a guardian angel of human reproduction?
Maccarrone M; Finazzi-Agrò A
Trends Pharmacol Sci; 2004 Jul; 25(7):353-7. PubMed ID: 15219977
[No Abstract] [Full Text] [Related]
35. Safrole: its metabolism, carcinogenicity and interactions with cytochrome P-450.
Ioannides C; Delaforge M; Parke DV
Food Cosmet Toxicol; 1981 Oct; 19(5):657-66. PubMed ID: 7030889
[No Abstract] [Full Text] [Related]
36. Perspectives in environmental hygiene and toxicology.
Parke DV
NIPH Ann; 1980 May; 3(1):3-14. PubMed ID: 7454124
[No Abstract] [Full Text] [Related]
37. AAAS Symposium on the Nature and Functional Role of Cytochrome P-450 Mediated Systems, 4 January 1979, Houston, Texas.
Drug Metab Rev; 1979; 10(1):1-87. PubMed ID: 43243
[No Abstract] [Full Text] [Related]
38. A role of mixed-function oxidation reactions in the accumulation of altered enzyme forms during aging.
Oliver CN; Levine RL; Stadtman ER
J Am Geriatr Soc; 1987 Oct; 35(10):947-56. PubMed ID: 3309015
[No Abstract] [Full Text] [Related]
39. The preparation of oxidized derivatives of 1-ethylsulfonyl-4-ethylpiperazine.
FOYE WO; FEDOR LR
J Am Pharm Assoc Am Pharm Assoc; 1959 Jul; 48(7):412-4. PubMed ID: 13672827
[No Abstract] [Full Text] [Related]
40. Antihypertensive drugs metabolism: an update to pharmacokinetic profiles and computational approaches.
Zisaki A; Miskovic L; Hatzimanikatis V
Curr Pharm Des; 2015; 21(6):806-22. PubMed ID: 25341854
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
